Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Divestments (2019 - 2024)

Quantum Biopharma's Divestments history spans 6 years, with the latest figure at $2.7 million for Q4 2024.

  • On a quarterly basis, Divestments rose 919.15% to $2.7 million in Q4 2024 year-over-year; TTM through Dec 2024 was -$0.0, a 100.0% increase, with the full-year FY2022 number at $12.7 million, changed N/A from a year prior.
  • Divestments hit $2.7 million in Q4 2024 for Quantum Biopharma, up from -$3.5 million in the prior quarter.
  • Over the last five years, Divestments for QNTM hit a ceiling of $4.3 million in Q1 2020 and a floor of -$3.5 million in Q3 2024.
  • Historically, Divestments has averaged $482301.7 across 5 years, with a median of $205488.4 in 2023.
  • Biggest five-year swings in Divestments: soared 1297.81% in 2020 and later tumbled 1184.78% in 2024.
  • Tracing QNTM's Divestments over 5 years: stood at $141397.8 in 2020, then crashed by 807.22% to -$1.0 million in 2021, then surged by 89.34% to -$106586.0 in 2022, then surged by 352.92% to $269579.0 in 2023, then soared by 919.15% to $2.7 million in 2024.
  • Business Quant data shows Divestments for QNTM at $2.7 million in Q4 2024, -$3.5 million in Q3 2024, and $738222.0 in Q2 2024.